Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targeted versus standard peri-operative antibiotic prophylaxis in carbapenemase-producing Enterobacterales-colonized liver transplant recipients
2025-523453-34-00Phase 3Authorised
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Aug 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of eravacycline, imipenem + cilastatin + relebactam, cefiderocol, ceftazidime + avibactam, meropenem + vaborbactam and 4 more in Enterobacterales infection, sponsored by Sant'Orsola-Malpighi University Hospital. Planned start Aug 2026; status: authorised.
02
Drugs
eravacyclineimipenem + cilastatin + relebactamcefiderocolceftazidime + avibactammeropenem + vaborbactam
03
Conditions
Enterobacterales infection
Beyond the preview
Go deeper on 2025-523453-34-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-523453-34-00.